Your skin changes. It feels tighter, wrinkles deepen, your complexion loses radiance, sometimes imperfections reappear after having been gone for a long time. You feel like your routine isn't working as it used to.
It's not your imagination. These are real, documented biological changes linked to the drop in estrogen levels. And understanding what's happening is essential to effectively adapt your routine.
Menopause doesn't age your skin. It changes the biological rules by which it operates.
What estrogens did for your skin
Estrogens don't just regulate the menstrual cycle. They are true skin regulators, with specific receptors present in keratinocytes, fibroblasts, melanocytes, sebaceous glands, and hair follicles.
Specifically, they stimulate the synthesis of collagen I and III by dermal fibroblasts, maintain hyaluronic acid production in the extracellular matrix, protect collagen from degradation by photo-induced enzymes, support sebaceous secretion, and maintain the integrity of the skin barrier. When their levels drop, this entire system shifts simultaneously.
What actually happens in your skin after menopause
The figures are precise and documented. Menopausal women without hormone therapy lose approximately 2% of their dermal collagen per year in the first years following the drop in estrogen, according to Brincat's work published in Climacteric. Over five years, collagen loss reaches 30%. This is a much faster rate than normal chronological aging.
Skin dryness affects 36% of menopausal women, according to a large study of 3,875 women. It results from the decrease in skin barrier lipids, especially ceramides and fatty acids, whose production is directly supported by estrogens. The skin retains less water, transepidermal water loss increases, and discomfort sets in.
Cell renewal slows down, the barrier deteriorates, elasticity decreases. Wrinkles deepen not because the skin "ages faster" but because the dermal framework that supports it becomes biologically weakened.
Perimenopause: when the changes really begin
The first skin changes can start as early as perimenopause, sometimes 3 to 5 years before menstruation definitively stops. The hormonal fluctuations during this transitional period are actually more abrupt than during established menopause. Skin that suddenly becomes drier, more reactive, with hormonal imperfections on the lower face: this is often the start of perimenopause, not a routine change to be made.
The really relevant active ingredients during this period
Retinol is the benchmark active ingredient for stimulating slowed cell renewal and supporting collagen production. Mature skin often tolerates it well, provided it is introduced gradually and sufficient hydration is maintained in parallel.
Peptides stimulate fibroblasts and support collagen and elastin synthesis without the potential irritation of retinol. They are particularly suitable for sensitized skin or at the beginning of retinization.
Ceramides and fatty acids directly compensate for the decrease in barrier lipids induced by estrogen deficiency. They restore the barrier's impermeability and reduce transepidermal water loss.
Low molecular weight hyaluronic acid compensates for the natural decrease of this molecule in the dermis, helping to maintain volume and deep hydration.
Low-concentration AHAs (glycolic acid, lactic acid) accelerate slowed cell renewal and improve texture and radiance. Introduce them gradually, never at the same time as retinol.
Niacinamide strengthens the barrier, regulates pigment irregularities that may worsen during this period, and supports ceramide production. It is the versatile support active ingredient for the menopause routine.
What is no longer enough and needs to evolve
A routine designed for 35-year-old skin no longer meets the needs of estrogen-deficient skin. Light textures that were previously sufficient may become inadequate in the face of increased dryness. Active ingredients used infrequently may require more regular integration. Photoprotection, always important, becomes even more of a priority because estrogens partially protected collagen from UV damage.
The Paradermia Approach
Our pharmacist adapts each protocol to the specificities of skin during menopause or perimenopause. Active ingredients are selected to address the biological mechanisms at play: barrier support, collagen stimulation, deep hydration, and complexion regulation. The routine evolves with you, not against you.
Frequently Asked Questions
Can I find a routine adapted to my menopausal skin on Paradermia?
Yes. Our pharmacist offers protocols specifically designed for skin changes related to menopause and perimenopause: restoration of the lipid barrier, collagen support, deep hydration, and enhanced sun protection. Each recommendation considers your tolerance and objectives.
Do I need to change my entire routine during menopause?
Not necessarily everything, but adjust. Textures, concentrations, and frequency of active ingredients must evolve to meet the skin's new biological needs. It's often a matter of enriching and adapting rather than starting over completely.
Does menopausal hormone therapy improve skin?
Yes, some studies show that hormone replacement therapy has a documented positive effect on skin dryness and wrinkles. This decision should be made in consultation with your gynecologist or doctor. Topical skincare remains essential in addition, whether or not there is hormone therapy.
Sources
- Thornton M.J. (2013). Estrogens and aging skin. Dermato-Endocrinology. doi:10.4161/derm.23872
- Brincat M, Versi E, Moniz CF, et al. (1987). Skin collagen changes in postmenopausal women receiving different regimens of estrogen therapy. Obstetrics & Gynecology. PMID:3601260
- Dunn L.B, Damesyn M, Moore A.A, et al. (1997). Does estrogen prevent skin aging? Results from the First National Health and Nutrition Examination Survey (NHANES I). Archives of Dermatology. doi:10.1001/archderm.133.3.339
- Lephart E.D, Naftolin F. (2022). Factors influencing skin aging and the important role of estrogens and selective estrogen receptor modulators (SERMs). Clinical, Cosmetic and Investigational Dermatology. doi:10.2147/CCID.S333663